CrossTalk opposing view: there is not added benefit to providing permissive hypercapnia in the treatment of ARDS.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Hypercapnia during acute respiratory distress syndrome: the tree that hides the forest!Journal of thoracic disease · 2017
   Article
2. Hypercapnia attenuates ventilator-induced lung injury via a disintegrin and metalloprotease-17.The Journal of physiology · 2014
   Article
3. Carbon dioxide-sensing in organisms and its implications for human disease.Cellular and molecular life sciences : CMLS · 2014
   Review
4. A mathematical model for carbon dioxide elimination: an insight for tuning mechanical ventilation.European journal of applied physiology · 2014
   Article
5. Rebuttal from Gerard F. Curley, John G. Laffey and Brian P. Kavanagh.The Journal of physiology · 2013
   Article

Corrections and comments

• Commented on by
  Rebuttal from Jeremy R. Beitler, Rolf D. Hubmayr and Atul Malhotra.2013
• Comment on
  CrossTalk proposal: there is added benefit to providing permissive hypercapnia in the treatment of ARDS.2013

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as